Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Ralph V. Boccia, MD, FACP
Authored Items
Unclear Diagnoses in Patients with Metastatic Disease
Ralph V. Boccia, MD, FACP
Videos
in
Interview with the Innovators
The bioT3 platform
Ralph V. Boccia, MD, FACP
Videos
in
Interview with the Innovators
Clinical Validation of CancerTYPE ID
Ralph V. Boccia, MD, FACP
Videos
in
Interview with the Innovators
CancerTYPE ID in the Clinic
Ralph V. Boccia, MD, FACP
Videos
in
Interview with the Innovators
CancerTREATMENT NGS+ in the Clinic
Ralph V. Boccia, MD, FACP
Videos
in
Interview with the Innovators
Managing Costs in Oncology Care
Ralph V. Boccia, MD, FACP
Videos
in
Interview with the Innovators
Last modified: April 14, 2015
